HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monique Dontenwill Selected Research

nutlin 3

8/2013Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monique Dontenwill Research Topics

Disease

27Neoplasms (Cancer)
08/2021 - 06/2006
14Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2009
11Glioma (Gliomas)
11/2021 - 02/2009
7Brain Neoplasms (Brain Tumor)
11/2019 - 01/2009
3Hypoxia (Hypoxemia)
03/2022 - 01/2020
3Astrocytoma (Pilocytic Astrocytoma)
05/2008 - 10/2005
2Bone Neoplasms (Bone Cancer)
03/2022 - 01/2020
2Osteosarcoma (Osteogenic Sarcoma)
03/2022 - 01/2020
2Squamous Cell Carcinoma of Head and Neck
06/2021 - 12/2015
2Carcinoma (Carcinomatosis)
08/2013 - 09/2010
1Necrosis
01/2020
1Basal Cell Carcinoma (Rodent Ulcer)
11/2018
1Neoplasm Metastasis (Metastasis)
12/2015
1Colonic Neoplasms (Colon Cancer)
08/2013
1Starvation
12/2003

Drug/Important Bio-Agent (IBA)

20IntegrinsIBA
01/2022 - 06/2006
6Biomarkers (Surrogate Marker)IBA
08/2021 - 12/2015
5Integrin alpha5beta1IBA
03/2021 - 06/2006
4Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 09/2010
4Small Interfering RNA (siRNA)IBA
05/2014 - 09/2010
3Proteins (Proteins, Gene)FDA Link
08/2021 - 08/2013
3Caveolin 1IBA
06/2021 - 02/2009
2Pharmaceutical PreparationsIBA
01/2022 - 06/2016
2Peptides (Polypeptides)IBA
01/2021 - 06/2016
2Membrane Proteins (Integral Membrane Proteins)IBA
09/2019 - 06/2017
2Phosphotransferases (Kinase)IBA
05/2019 - 10/2005
2Fibronectins (Fibronectin)IBA
11/2018 - 01/2016
2Antineoplastic Agents (Antineoplastics)IBA
06/2016 - 01/2009
2ellipticineIBA
09/2010 - 01/2009
2SJ749IBA
02/2009 - 06/2006
12-toluenesulfonamide (OTS)IBA
03/2022
1SolventsIBA
06/2021
1Cetuximab (Erbitux)FDA Link
06/2021
1A-Form DNA (A-DNA)IBA
05/2021
1Gefitinib (Iressa)FDA Link
03/2021
1Tyrosine Kinase InhibitorsIBA
03/2021
1Integrin alpha5IBA
03/2021
1PeptidomimeticsIBA
01/2021
1Biological ProductsIBA
01/2021
1LigandsIBA
01/2021
1Oxygen (Dioxygen)IBA
04/2020
1RNA (Ribonucleic Acid)IBA
11/2019
1Histones (Histone)IBA
11/2019
1Cell Surface ReceptorsIBA
09/2019
1Nucleotide AptamersIBA
09/2019
1tyrosine receptor (receptor, tyrosine)IBA
05/2019
1Growth Factor ReceptorsIBA
05/2019
1adhesion receptorIBA
05/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2018
1Nucleic AcidsIBA
06/2017
1beta CateninIBA
09/2016
1CateninsIBA
09/2016
1cyclic arginine-glycine-aspartic acid peptideIBA
06/2016
1Transcription Factors (Transcription Factor)IBA
05/2014
1nutlin 3IBA
08/2013
1LuciferasesIBA
02/2012
1Cell Adhesion MoleculesIBA
01/2012
1DNA AdductsIBA
01/2009
1Integrin beta1IBA
05/2008
1StaurosporineIBA
12/2003
1ThapsigarginIBA
12/2003

Therapy/Procedure

15Therapeutics
06/2021 - 09/2010
5Drug Therapy (Chemotherapy)
06/2021 - 09/2010
4Radiotherapy
06/2021 - 01/2012
1Lab-On-A-Chip Devices
11/2021
1Adjuvant Radiotherapy
06/2021
1Immunotherapy
04/2021
1Adjuvant Chemotherapy
01/2012